Low Dose Wegovy vs Mounjaro UK | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Cheapest Low Dose Wegovy vs Mounjaro - UK Price £69.00

Compare low dose Wegovy and Mounjaro at the cheapest UK price from £69.00 plus £20 off your first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Low Dose Wegovy vs Mounjaro: Compare Both Options

Published on: June 03, 2026

Choosing between low dose Wegovy vs Mounjaro UK options requires understanding how each medication performs at maintenance levels. At Cured Pharmacy, our UK-registered clinical team helps patients navigate the differences between semaglutide and tirzepatide for sustained weight management, with transparent pricing and expert prescriber support throughout your treatment journey.

Understanding Low Dose Wegovy for Weight Maintenance

Wegovy (semaglutide) follows a structured dose escalation protocol, typically reaching a maintenance dose of 1.7mg or 2.4mg weekly [1]. Many patients ask whether they can remain on lower doses—such as 0.5mg or 1mg—for long-term weight maintenance after achieving their initial goals.

Clinical evidence from the STEP trials demonstrates that the full 2.4mg dose produces optimal weight loss outcomes, with participants achieving an average 14.9% body weight reduction over 68 weeks [1]. However, some patients may experience adequate weight maintenance on lower doses, particularly if they've already lost significant weight and are focusing on stabilisation rather than continued reduction.

The decision to stay on a lower Wegovy dose must be made in consultation with your UK prescriber, who will assess your individual response, side effect profile, and weight management goals. Some patients tolerate lower doses better whilst maintaining their weight loss, whilst others require the full therapeutic dose to prevent weight regain [2].

How Mounjaro Differs from Low Dose Wegovy

Mounjaro (tirzepatide) represents a distinct pharmacological approach as the UK's first dual GIP/GLP-1 receptor agonist [3]. Whilst Wegovy activates only the GLP-1 pathway, Mounjaro simultaneously targets both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, producing enhanced metabolic effects.

The SURPASS-2 trial directly compared tirzepatide with semaglutide 1mg, demonstrating that Mounjaro's highest dose (15mg) produced significantly greater weight reduction—an average of 12.4kg compared to 6.2kg with semaglutide over 40 weeks [3]. This dual-action mechanism may offer advantages for patients who plateau on semaglutide-based treatments.

Mounjaro's dosing schedule also differs, with maintenance doses ranging from 5mg to 15mg weekly depending on individual response and tolerability. The lower starting doses (2.5mg) help minimise gastrointestinal side effects during the initial titration period, similar to Wegovy's escalation protocol [4].

Dual Receptor Activation Explained

The GIP receptor plays a crucial role in insulin secretion and may influence fat metabolism differently than GLP-1 alone [3]. This dual mechanism explains why patients on Mounjaro often experience greater appetite suppression and more substantial weight loss compared to single-pathway GLP-1 agonists, even at comparable doses.

Clinical Efficacy: Low Dose Wegovy vs Mounjaro UK Studies

When comparing low dose options, it's essential to examine real-world efficacy data. The STEP 1 trial showed that even participants who didn't reach the full 2.4mg Wegovy dose still achieved meaningful weight loss, though outcomes were dose-dependent [1]. Patients on 1.7mg experienced approximately 12-13% body weight reduction, compared to 14.9% at the full dose.

For Mounjaro, the SURMOUNT-1 trial demonstrated that even the mid-range 10mg dose produced an average 19.5% weight reduction over 72 weeks—exceeding the results seen with maximum-dose semaglutide [4]. The 15mg Mounjaro dose achieved up to 22.5% body weight reduction in clinical trials, representing the highest efficacy among currently licensed weight management medications in the UK.

These comparative data suggest that patients who struggle to tolerate or respond adequately to low dose Wegovy may achieve better outcomes by switching to Mounjaro, where even moderate doses produce substantial metabolic benefits. However, individual response varies considerably, and some patients thrive on lower-dose semaglutide with fewer side effects.

Weight Maintenance vs Active Loss Phase

The distinction between active weight loss and maintenance phases influences dosing decisions significantly. Patients who've achieved their target weight may find that a lower Wegovy dose (1mg or 1.7mg) suffices for maintenance, particularly when combined with lifestyle modifications. Your UK prescriber will monitor your weight trajectory and adjust dosing accordingly to prevent regain whilst minimising medication burden.

Feature Low Dose Wegovy Mounjaro
Active Ingredient Semaglutide (GLP-1 agonist) Tirzepatide (dual GIP/GLP-1 agonist)
Typical Maintenance Dose 1mg - 2.4mg weekly 5mg - 15mg weekly
Average Weight Loss (clinical trials) 12-15% body weight 15-22.5% body weight
Starting Price at Cured Pharmacy From £69.00 From £69.00
Injection Frequency Once weekly Once weekly
Common Side Effects Nausea, vomiting, diarrhoea Nausea, vomiting, diarrhoea
Best For Weight maintenance, cost-conscious patients Active weight loss, plateau breakers

Side Effect Profiles: What to Expect on Lower Doses

Both Wegovy and Mounjaro share similar side effect profiles, predominantly gastrointestinal symptoms including nausea, vomiting, diarrhoea, and constipation [1][3]. These effects are typically dose-dependent, meaning lower doses generally produce milder symptoms.

Patients on low dose Wegovy (0.5mg to 1mg) often report better tolerability compared to the full 2.4mg dose, with nausea affecting approximately 20-30% of users at lower doses versus 44% at maximum dose [2]. This improved tolerability is a key reason some patients prefer to remain on sub-maximal doses for long-term maintenance.

Mounjaro's side effect incidence also correlates with dose escalation. The 5mg maintenance dose produces fewer gastrointestinal complaints than the 15mg dose, though the dual receptor mechanism may cause slightly different symptom patterns compared to semaglutide [4]. Some patients find Mounjaro's side effects more manageable despite higher efficacy, whilst others tolerate Wegovy better—individual variation is substantial.

Cost Considerations for Low Dose Wegovy vs Mounjaro UK

Pricing structures for weight loss medications vary across UK pharmacies, with dose strength significantly impacting overall treatment costs. At Cured Pharmacy, Mounjaro is available from £124.99, whilst Wegovy starts from £135.00, with final pricing determined by your prescribed dose and treatment duration.

Patients considering long-term maintenance on lower doses should factor in the cumulative cost over months or years. Whilst lower doses may reduce per-pen expenses, the total cost-effectiveness depends on whether the reduced dose maintains your weight loss adequately or whether you experience regain requiring dose escalation.

Some patients find that investing in a higher-dose, more efficacious treatment like Mounjaro ultimately proves more cost-effective than prolonged use of sub-optimal Wegovy doses that fail to prevent weight regain. Your UK prescriber can help evaluate the clinical and financial trade-offs based on your individual response pattern and weight management goals.

Transparent Pricing at Cured Pharmacy

Unlike many online services, Cured Pharmacy displays upfront pricing before your consultation, ensuring no hidden costs. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all dispensing, guaranteeing you receive genuine UK-licensed medications at the lowest prices in the UK market. All prescription treatments require a free online clinical assessment by our UK-registered prescribers, typically completed in under three minutes.

Making the Right Choice: Low Dose Wegovy vs Mounjaro for Your Needs

Selecting between low dose Wegovy and Mounjaro depends on multiple factors: your weight loss history, current BMI, side effect tolerance, budget, and whether you're in an active loss phase or maintenance period. Patients who've achieved significant weight loss on Wegovy and are now maintaining may find lower doses sufficient with proper lifestyle support.

Conversely, individuals who've plateaued on semaglutide or haven't reached their target weight may benefit from switching to Mounjaro's dual-action mechanism. The enhanced efficacy of tirzepatide can overcome resistance to single-pathway GLP-1 agonists, though this must be balanced against potential differences in side effect profiles and cost.

At Cured Pharmacy, our UK clinical team conducts thorough assessments to determine which medication and dose align with your medical history and weight management objectives. We monitor your progress and adjust treatment as needed, ensuring you receive optimal support throughout your journey. All consultations are conducted by UK-registered prescribers in compliance with MHRA and GPhC regulations, with discreet packaging and next-day delivery options available across the UK.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  2. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., Rudofsky, G., Tadayon, S., Wadden, T. A., Dicker, D., & STEP 4 Investigators. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
  3. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., Brown, K. D., SURPASS-2 Investigators. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
  4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary by individual and depend on multiple factors including diet, exercise, and adherence to treatment. Claims regarding efficacy are based on clinical trial data and may not reflect individual outcomes.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I stay on low dose Wegovy permanently for weight maintenance?
Some patients successfully maintain weight loss on lower Wegovy doses (0.5mg-1mg), though this must be determined by your UK prescriber based on your individual response and whether you experience weight regain. Clinical trials show optimal results at 2.4mg, but maintenance strategies vary by patient.
Is Mounjaro more effective than low dose Wegovy?
Clinical trials demonstrate that Mounjaro produces greater average weight loss than semaglutide, even when comparing moderate Mounjaro doses to maximum-dose Wegovy. However, individual response varies, and some patients achieve excellent results on lower-dose semaglutide with better tolerability.
What happens if I reduce my Wegovy dose too much?
Reducing Wegovy below your effective therapeutic dose may result in weight regain, as the medication's appetite-suppressing and metabolic effects diminish at sub-optimal levels. Your UK prescriber will monitor your weight trajectory and adjust dosing to maintain your results whilst minimising side effects.
Can I switch from low dose Wegovy to Mounjaro?
Yes, switching from semaglutide to tirzepatide is possible under prescriber supervision. Your UK clinician will determine the appropriate starting dose of Mounjaro based on your current Wegovy dose and treatment response, typically beginning with the 2.5mg titration dose to minimise side effects.
How long does it take to see results on low dose Wegovy vs Mounjaro?
Most patients notice appetite suppression within 1-2 weeks on either medication, with measurable weight loss typically evident by 4-8 weeks. Mounjaro may produce faster initial results due to its dual-action mechanism, though both medications require several months to achieve maximum efficacy.
Are the side effects worse on Mounjaro compared to low dose Wegovy?
Side effect severity correlates more with dose than medication type. Low dose Wegovy generally produces milder symptoms than maximum-dose Wegovy or high-dose Mounjaro. However, individual tolerance varies—some patients find Mounjaro's side effects more manageable despite comparable or higher doses.
Does Cured Pharmacy offer both low dose Wegovy and Mounjaro?
Yes, Cured Pharmacy provides both Wegovy (from £135.00) and Mounjaro (from £124.99) following a free online consultation with our UK-registered prescribers. We'll assess your medical history and weight management goals to recommend the most appropriate medication and dose for your individual needs.
Will my weight loss plateau if I stay on low dose Wegovy?
Weight loss typically plateaus after 6-12 months on any dose as your body adapts metabolically. Staying on a lower Wegovy dose may result in an earlier or more pronounced plateau compared to maximum-dose treatment. Your prescriber can adjust your dose or consider switching to Mounjaro if plateau occurs.
Is low dose Wegovy or Mounjaro cheaper in the UK?
Low dose Wegovy starts from £69.00 for 0.25mg, making it cheaper than Mounjaro's starting dose of 2.5mg at £124.99. Cured Pharmacy offers both with transparent pricing and £20 off your first order using code Weightlossnew, helping you choose the most cost-effective option for your weight loss journey.
Can I switch from low dose Wegovy to Mounjaro in the UK?
Yes, you can switch between Wegovy and Mounjaro under medical supervision. Cured Pharmacy's UK-registered prescribers will assess your progress on low dose Wegovy and determine if switching to Mounjaro is appropriate based on your response, tolerability, and weight loss goals.
Which is more effective at low doses - Wegovy or Mounjaro?
Clinical studies suggest Mounjaro may offer greater weight loss even at starting doses due to its dual hormone action, though Wegovy is also highly effective. Cured Pharmacy's prescribers can help you compare low dose Wegovy vs Mounjaro UK options based on your individual health profile and weight loss targets.
Do low dose Wegovy and Mounjaro have the same side effects?
Both medications share common side effects like nausea and digestive issues at low doses, though individual experiences vary. Starting with lower doses of either Wegovy or Mounjaro helps minimize side effects, and Cured Pharmacy provides ongoing support to manage any symptoms during your treatment.
How long should I stay on low dose Wegovy before considering Mounjaro?
Most patients complete Wegovy's full dose escalation over 16-20 weeks before considering alternatives. If you experience plateaus or inadequate results on low dose Wegovy, Cured Pharmacy's prescribers can evaluate whether switching to Mounjaro might provide better outcomes for your weight loss goals.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.